# OnCo record belumosudil (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/belumosudil/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "belumosudil" ;
  schema:name "Belumosudil"@en ;
  schema:description "Belumosudil is a pill for chronic graft-versus-host disease, the long-term immune complication of donor stem-cell transplants used to cure blood cancers."@en ;
  schema:url <https://onco.cc/drugs/belumosudil/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Belumosudil> ;
  owl:sameAs <http://www.wikidata.org/entity/Q27269397> ;
  schema:citation <https://doi.org/10.1182/blood.2021012021>, <https://doi.org/10.1158/1078-0432.CCR-21-4176>, <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=belumosudil> ;
  onco:status "approved" ;
  onco:tag "gap-fill", "supportive" ;
  onco:modality "Oral ROCK2 inhibitor" ;
  schema:alternateName "Rezurock" ;
  onco:approval "US 2021: Chronic GVHD after failure of ≥2 lines of systemic therapy (age ≥12)" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/mds/> ;
  onco:sections <https://onco.cc/fronts/rejuvenation/> ;
  onco:technologies <https://onco.cc/technologies/allogeneic-hsct/>, <https://onco.cc/technologies/kinase-inhibitors/>, <https://onco.cc/technologies/gvhd-belumosudil-axatilimab-ibrutinib/> ;
  onco:companies <https://onco.cc/companies/sanofi/> ;
  onco:trials <https://onco.cc/trials/rockstar/> .